FDA Inspection
Boston Analytical, Inc.Boston Analytical, Inc. – FDA Inspection, Jan 24, 2020
Record Details
This FDA Inspection record concerns Boston Analytical, Inc., with an inspection on January 24, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Boston Analytical, Inc.
- Inspection Date
- January 24, 2020
- Product Type
- Drugs
View Company Profile
ID · 27999c69-291d-43e4-8c15-172499a9e849
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1115784
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.165(c)Sampling and testing plans not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Boston Analytical, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2023 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| January 15, 2019 | NAI | Center for Veterinary Medicine | Generic Drug Evaluation |
| September 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Boston Analytical, Inc.
- FDA Inspection 1200703 - 2023-03-07
- FDA Inspection 1076790 - 2019-01-15
- FDA Inspection 987020 - 2016-09-22
- FDA Inspection 941530 - 2015-06-23
- FDA Inspection 814115 - 2012-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.